• US: +1 9176726599
  • Login

3D Bioprinting Market by Technology (Laser-based, Inkjet-based, Magnetic Levitation, Syringe-based, Others), Application (Medical, Medical pills, Tissue and organ generation, Prosthetics and implants, Dental, Bioinks, Biosensors, Consumer/Personal Product Testing, Food and Animal Product), Material (Living Cells, Hydrogels, Extracellular Matrices, Others), End User & Region - Global Forecast to 2030

Format: PDF | Pages: 332 | Report ID: MRS1100


Report Description

The global 3D Bioprinting market size is estimated at USD 920.1 million in 2020, expanding at a CAGR 23.8% from 2021-2027 to reach 1,992.7 million USD in 2027.

3D bioprinting is a new field in the healthcare sector that is seeing rapid technological improvements, which is driving up the need for trained personnel who can run these systems successfully. Constant process monitoring is required for optimal usage of the 3D bioprinting technique. Due to uncontrollable process variables (such as batch and machine variations) and material differences, the reliability of the process differs across platforms.

Market Dynamics

The use of 3D bioprinting technology in the healthcare business has grown in recent years. Bioprinting has emerged as a potential method for fabricating artificial tissues and organs, with the potential to transform clinical analysis and medical intervention. Bioprinting companies are constantly innovating in regenerative medicine, tissue regeneration, drug therapies, and stem cell treatments, which is attracting the attention of health care providers and the drug industry who see a career with better patient care, personalized medical treatment, and a substitute to organ transplants.

Technology Segment Insights

Because it allows for the printing of complex live organs and systems on culture substrates utilizing biomaterials as bio-inks, the inkjet-based sector commanded the 3D bioprinting industry in 2020, contributing for 36.0 percent of total income. The increasing use of inkjet-based interest in the medical industry is assisting the segment's growth. This study discusses the methods of inkjet printing as a bio applicable technique, notably in the areas of tissue engineering and medication supply chain management. This market is predicted to grow considerably during the forecast timeframe due to the rising consumption and higher dependability.

Application Segment Insights

In 2020, the medical category dominated the 3D bioprinting market, accounting for 36.2 percent of total revenue. The widespread use of prescription tablets to treat a variety of chronic ailments is fueling the demand for 3D bioprinting. Furthermore, the growing demand for medications, as well as the cost-effective use of bio-drugs employing this technology, are propelling the market forward. The demand for medicinal tablets is expanding as the number of participants in the pharmaceutical sector grows. Capsules and medical pills are used by millions of individuals around the world on a daily basis. As a result, this market is likely to develop at a healthy rate over the next years.

Regional Segment Insights

In 2020, North America dominated the 3D bioprinting market, accounting for 32.4 percent of total revenue. Over the forecast period, the market is expected to rise due to the increasing adoption of IT in the healthcare industry. According to the World Meter Report 2021, there were about 23,369,732 active cases of Covid-19 recorded in the United States alone from January 13 to January 13, 2021. The government is increasing its research and development budget in an attempt to create a vaccine for this disease. As a result of this, there is a growing need for 3D bioprinting, which has been validated for drug testing and organ transplantation.

Competitive Insights

Some of the major players in this industry include 3D Systems, Inc., Stratasys Ltd, Renishaw plc, Organovo Holding Inc., GeSiM, GE Healthcare, Formlabs Inc., ExOne, EOS GmbH Electro Optical Systems, Envision TEC, Cyfuse Medical K.K, and others.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products, etc.):

  • 3D Systems, Inc.
  • Stratasys Ltd
  • Renishaw plc
  • Organovo Holding Inc.
  • GeSiM
  • GE Healthcare
  • Formlabs Inc.
  • ExOne
  • EOS GmbH
  • Electro Optical Systems
  • Envision TEC
  • Cyfuse Medical K.K
  • Others

Technology Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Laser-based
  • Inkjet-based
  • Magnetic Levitation
  • Syringe-based
  • Others

Application Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Medical
    • Medical pills
    • Tissue and organ generation
    • Prosthetics and implants
  • Dental
  • Bioinks
  • Biosensors
  • Consumer/Personal Product Testing
  • Food and Animal Product

Material Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Others

End User Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Research Organization
  • Academic Institutes
  • Biopharmaceuticals Companies
  • Hospital
  • Others

Region Coverage (Regional Consumption, Demand & Forecast by Countries, etc.):

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

Frequently Asked Questions

The global 3D Bioprinting market size is estimated at USD 920.1 million in 2020, expanding at a CAGR 23.8% from 2021-2027 to reach 1,992.7 million USD in 2027.
North America captured the highest revenue in 2021 and is projected to continue its dominance during the study period.
The global 3D Bioprinting market size is expanding at a CAGR 23.8% from 2021-2027 to reach 1,992.7 million USD in 2027.
Asia Pacific (especially China, and India) region is projected to grow at the fastest growth rate during the study period.
Some of the major players in this industry include 3D Systems, Inc., Stratasys Ltd, Renishaw plc, Organovo Holding Inc., GeSiM, GE Healthcare, Formlabs Inc., ExOne, EOS GmbH Electro Optical Systems, Envision TEC, Cyfuse Medical K.K, and others.

Why Choose Market Research Strategy?

  Authenticated Data Sources

We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports

  Express Delivery

We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround

  Gain Instant Access

Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.

  Our Pledge to You

We abide by the information security policy and adheres to keep your private and business information confidential and secure.

Copyright © 2022 Market Research Strategy, All rights reserved.